3-129001651-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001377500.1(EFCC1):c.23C>T(p.Ala8Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,392,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001377500.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EFCC1 | NM_001377500.1 | c.23C>T | p.Ala8Val | missense_variant | 1/8 | ENST00000683648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EFCC1 | ENST00000683648.1 | c.23C>T | p.Ala8Val | missense_variant | 1/8 | NM_001377500.1 | |||
EFCC1 | ENST00000436022.2 | c.23C>T | p.Ala8Val | missense_variant | 1/8 | 5 | P1 | ||
CFAP92 | ENST00000510149.1 | n.117+923G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000404 AC: 1AN: 24780Hom.: 0 AF XY: 0.0000722 AC XY: 1AN XY: 13858
GnomAD4 exome AF: 0.0000145 AC: 18AN: 1240624Hom.: 0 Cov.: 35 AF XY: 0.00000996 AC XY: 6AN XY: 602628
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2024 | The c.23C>T (p.A8V) alteration is located in exon 1 (coding exon 1) of the EFCC1 gene. This alteration results from a C to T substitution at nucleotide position 23, causing the alanine (A) at amino acid position 8 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at